News

Best Momentum Stocks to Buy for January 7th

NN, VERX and AORT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 7, 2024.

01/07/2025

New Strong Buy Stocks for January 7th

AORT, VERX, NN, IMCR and EVER have been added to the Zacks Rank #1 (Strong Buy) List on January 7, 2024.

01/07/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Artivion, Inc. (AORT) a buy, sell, or hold?

Artivion, Inc. (AORT) can sell. Click on Rating Page for detail.

What is Artivion, Inc.'s stock price?

The price of Artivion, Inc. (AORT) is 29.99 and it was updated on 2025-01-15 07:00:37.

Is Artivion, Inc. (AORT) overvalued or undervalued?

Currently Artivion, Inc. (AORT) is in undervalued.

News

From:

To:

News
US medical device giant Artivion says hackers stole files during cybersecurity incident Artivion, a medical device company that manufactures implantable tissues for cardiac and vascular transplant applications, says its services have been “disrupted” due to a cybersecurity incident. Mon, Dec. 09, 2024
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis ATLANTA , Dec. 9, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) for use of the AMDS Hybrid Prosthesis ("AMDS") in acute DeBakey Type I dissections in the presence of malperfusion. The AMDS is the world's first aortic arch remodeling device for use in the treatment of acute DeBakey Type I aortic dissections. Mon, Dec. 09, 2024
Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Dorothy Morgan - Gilmartin Group LLC Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants Daniel Stauder - JMP Securities Suraj Kalia - Oppenheimer Nelson Cox - Lake Street Capital Mike Matson - Needham & Company Jeffrey Cohen - Ladenburg Thalmann Operator Greetings, and welcome to the Artivion Third Quarter 2024 Financial Conference Call. At this time, all participants are in listen only mode. Sat, Nov. 09, 2024
Artivion (AORT) Tops Q3 Earnings and Revenue Estimates Artivion (AORT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago. Thu, Nov. 07, 2024
Artivion Reports Third Quarter 2024 Financial Results Third Quarter Highlights: Achieved revenue of $95.8 million in the third quarter of 2024 versus $87.9 million in the third quarter of 2023, an increase of 9% on a GAAP basis and 10% on a non-GAAP constant currency basis Net loss was ($2.3) million or ($0.05) per fully diluted share and non-GAAP net income was $5.0 million or $0.12 per fully diluted share in the third quarter of 2024 Adjusted EBITDA increased 28% to $17.7 million in the third quarter of 2024 compared to $13.9 million in the third quarter of 2023 Submitted first module of the pre-market approval application (PMA) for AMDS Hybrid Prosthesis with the U.S. Food and Drug Administration Enrollment completed in NEXUS TRIOMPHE clinical trial Received regulatory approval from the National Medical Products Administration (NMPA) to commercialize BioGlue Surgical Adhesive in China. Commercialization expected in the second half of 2025. Thu, Nov. 07, 2024

Transcripts

Transcipts Data
Artivion, Inc. (AORT) on Q3 2024 Results - Earnings Call Transcript SA Transcripts Sat, Nov. 09, 2024
Artivion, Inc. (AORT) on Q2 2024 Results - Earnings Call Transcript SA Transcripts Sat, Aug. 10, 2024
Artivion, Inc. (AORT) on Q1 2024 Results - Earnings Call Transcript SA Transcripts Mon, May. 06, 2024
Artivion, Inc. (AORT) on Q4 2023 Results - Earnings Call Transcript SA Transcripts Thu, Feb. 15, 2024
Artivion, Inc. (AORT) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Sun, Nov. 05, 2023
Artivion, Inc. (AORT) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Sat, Aug. 05, 2023
Artivion, Inc. (AORT) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Sun, May. 07, 2023
Artivion, Inc. (AORT) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Thu, Feb. 16, 2023
Artivion, Inc. (AORT) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Sat, Nov. 05, 2022
Artivion, Inc. (AORT) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Sun, Aug. 07, 2022
Artivion, Inc. (AORT) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Sun, May. 08, 2022
Artivion, Inc. (AORT) on Q4 2021 Results - Earnings Call Transcript SA Transcripts Thu, Feb. 17, 2022

SEC Filings

SEC Filings
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/23/2024
Artivion, Inc. (AORT) - 4 SEC Filings 12/13/2024
Artivion, Inc. (AORT) - 4 SEC Filings 12/12/2024
Artivion, Inc. (AORT) - 4/A SEC Filings 12/10/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/09/2024
Artivion, Inc. (AORT) - 4 SEC Filings 12/09/2024
Artivion, Inc. (AORT) - 4 SEC Filings 12/04/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 11/08/2024
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 11/08/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/07/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 10/18/2024
Artivion, Inc. (AORT) - 4 SEC Filings 10/02/2024
Artivion, Inc. (AORT) - 4 SEC Filings 08/27/2024
Artivion, Inc. (AORT) - 4 SEC Filings 08/19/2024
Artivion, Inc. (AORT) - 4 SEC Filings 08/16/2024
Artivion, Inc. (AORT) - 4 SEC Filings 08/15/2024
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 08/09/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/08/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/01/2024
Artivion, Inc. (AORT) - 4 SEC Filings 06/03/2024
Artivion, Inc. (AORT) - SD SEC Filings 05/30/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/17/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/16/2024
Artivion, Inc. (AORT) - 4 SEC Filings 05/13/2024
Artivion, Inc. (AORT) - 4 SEC Filings 05/10/2024
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 05/07/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/06/2024
Artivion, Inc. (AORT) - DEFA14A SEC Filings 04/01/2024
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/01/2024
Artivion, Inc. (AORT) - ARS SEC Filings 04/01/2024
Artivion, Inc. (AORT) - PRE 14A SEC Filings 03/21/2024
Artivion, Inc. (AORT) - 4 SEC Filings 03/21/2024
Artivion, Inc. (AORT) - 4 SEC Filings 03/18/2024
Artivion, Inc. (AORT) - 4 SEC Filings 03/15/2024
Artivion, Inc. (AORT) - 4/A SEC Filings 03/14/2024
Artivion, Inc. (AORT) - 4 SEC Filings 03/14/2024
Artivion, Inc. (AORT) - SC 13G SEC Filings 03/11/2024
Artivion, Inc. (AORT) - 4 SEC Filings 03/07/2024
Artivion, Inc. (AORT) - S-3ASR SEC Filings 03/01/2024
Artivion, Inc. (AORT) - 4 SEC Filings 02/29/2024
Artivion, Inc. (AORT) - 4 SEC Filings 02/28/2024
Artivion, Inc. (AORT) - 4 SEC Filings 02/26/2024
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/23/2024
Artivion, Inc. (AORT) - 4 SEC Filings 02/22/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/15/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/13/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/12/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/08/2024
Artivion, Inc. (AORT) - 5 SEC Filings 01/30/2024
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/22/2024
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/18/2024
Artivion, Inc. (AORT) - 4 SEC Filings 01/04/2024
Artivion, Inc. (AORT) - 4 SEC Filings 12/19/2023
Artivion, Inc. (AORT) - 4 SEC Filings 12/08/2023
Artivion, Inc. (AORT) - 3 SEC Filings 12/08/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/06/2023
Artivion, Inc. (AORT) - 4 SEC Filings 11/29/2023
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 11/03/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/02/2023
Artivion, Inc. (AORT) - 4 SEC Filings 08/10/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/08/2023
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 08/04/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/03/2023
Artivion, Inc. (AORT) - 3 SEC Filings 06/30/2023
Artivion, Inc. (AORT) - 4 SEC Filings 06/12/2023
Artivion, Inc. (AORT) - S-8 SEC Filings 06/09/2023
Artivion, Inc. (AORT) - 4 SEC Filings 06/08/2023
Artivion, Inc. (AORT) - 3 SEC Filings 06/08/2023
Artivion, Inc. (AORT) - SD SEC Filings 05/30/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/19/2023
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 05/05/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/04/2023
Artivion, Inc. (AORT) - ARS SEC Filings 04/05/2023
Artivion, Inc. (AORT) - DEFA14A SEC Filings 04/03/2023
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/03/2023
Artivion, Inc. (AORT) - 4 SEC Filings 03/03/2023
Artivion, Inc. (AORT) - 4 SEC Filings 03/01/2023
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/23/2023
Artivion, Inc. (AORT) - 4 SEC Filings 02/21/2023
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/16/2023
Artivion, Inc. (AORT) - 4 SEC Filings 02/16/2023
Artivion, Inc. (AORT) - 4 SEC Filings 02/15/2023
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2023
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/10/2023
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/09/2023
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/08/2023
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/06/2023
Artivion, Inc. (AORT) - 5 SEC Filings 01/27/2023
Artivion, Inc. (AORT) - SC 13G SEC Filings 01/20/2023
Artivion, Inc. (AORT) - 4 SEC Filings 12/16/2022
Artivion, Inc. (AORT) - 4 SEC Filings 11/10/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/09/2022
Artivion, Inc. (AORT) - 4 SEC Filings 11/07/2022
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 11/04/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/03/2022
Artivion, Inc. (AORT) - 3 SEC Filings 10/07/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/29/2022
Artivion, Inc. (AORT) - SC 13D SEC Filings 09/26/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/23/2022
Artivion, Inc. (AORT) - 4 SEC Filings 08/18/2022
Artivion, Inc. (AORT) - 4 SEC Filings 08/10/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/05/2022
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 08/05/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/04/2022
Artivion, Inc. (AORT) - 4 SEC Filings 06/03/2022
Artivion, Inc. (AORT) - SD SEC Filings 05/26/2022
Artivion, Inc. (AORT) - S-8 SEC Filings 05/24/2022
Artivion, Inc. (AORT) - S-8 SEC Filings 05/23/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/20/2022
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 05/06/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/05/2022
Artivion, Inc. (AORT) - DEFA14A SEC Filings 04/04/2022
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/04/2022
Artivion, Inc. (AORT) - 4 SEC Filings 03/09/2022
Artivion, Inc. (AORT) - 4 SEC Filings 03/07/2022
Artivion, Inc. (AORT) - 4 SEC Filings 03/01/2022
Artivion, Inc. (AORT) - 4 SEC Filings 02/24/2022
Artivion, Inc. (AORT) - 4 SEC Filings 02/22/2022
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/22/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/17/2022
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2022
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/11/2022
Artivion, Inc. (AORT) - 4 SEC Filings 02/11/2022
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/10/2022
Artivion, Inc. (AORT) - 5 SEC Filings 02/10/2022
Artivion, Inc. (AORT) - 4 SEC Filings 02/10/2022
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/09/2022
Artivion, Inc. (AORT) - 4 SEC Filings 02/08/2022
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/27/2022
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/25/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/20/2022
Artivion, Inc. (AORT) - 8-A12B/A SEC Filings 01/06/2022
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/04/2022
Artivion, Inc. (AORT) - 4 SEC Filings 12/10/2021
Artivion, Inc. (AORT) - 4 SEC Filings 12/01/2021
Artivion, Inc. (AORT) - 4 SEC Filings 11/30/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/18/2021
Artivion, Inc. (AORT) - 4 SEC Filings 11/05/2021
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 11/05/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/04/2021
Artivion, Inc. (AORT) - DEFA14A SEC Filings 10/07/2021
Artivion, Inc. (AORT) - DEF 14A SEC Filings 10/07/2021
Artivion, Inc. (AORT) - 3 SEC Filings 10/07/2021
Artivion, Inc. (AORT) - PRE 14A SEC Filings 09/24/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/22/2021
Artivion, Inc. (AORT) - 4 SEC Filings 09/01/2021
Artivion, Inc. (AORT) - 4 SEC Filings 08/31/2021
Artivion, Inc. (AORT) - 4 SEC Filings 08/26/2021
Artivion, Inc. (AORT) - 4 SEC Filings 08/24/2021
Artivion, Inc. (AORT) - S-3ASR SEC Filings 08/11/2021
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/30/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/29/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/02/2021
Artivion, Inc. (AORT) - 4 SEC Filings 06/02/2021
Artivion, Inc. (AORT) - SD SEC Filings 05/28/2021
Artivion, Inc. (AORT) - 4 SEC Filings 05/27/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/25/2021
Artivion, Inc. (AORT) - 3/A SEC Filings 05/19/2021
Artivion, Inc. (AORT) - 4 SEC Filings 05/10/2021
Artivion, Inc. (AORT) - 4 SEC Filings 05/07/2021
Artivion, Inc. (AORT) - 4 SEC Filings 05/04/2021
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/30/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/29/2021
Artivion, Inc. (AORT) - DEFA14A SEC Filings 03/30/2021
Artivion, Inc. (AORT) - DEF 14A SEC Filings 03/30/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/29/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/23/2021
Artivion, Inc. (AORT) - 4 SEC Filings 03/18/2021
Artivion, Inc. (AORT) - 3 SEC Filings 03/18/2021
Artivion, Inc. (AORT) - 4 SEC Filings 03/15/2021
Artivion, Inc. (AORT) - 4 SEC Filings 03/11/2021
Artivion, Inc. (AORT) - 4 SEC Filings 03/10/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/08/2021
Artivion, Inc. (AORT) - 4 SEC Filings 03/02/2021
Artivion, Inc. (AORT) - 4 SEC Filings 02/25/2021
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/23/2021
Artivion, Inc. (AORT) - 4 SEC Filings 02/19/2021
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/12/2021
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/11/2021
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/11/2021
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/10/2021
Artivion, Inc. (AORT) - SC 13G SEC Filings 01/25/2021
Artivion, Inc. (AORT) - 5 SEC Filings 01/11/2021
Artivion, Inc. (AORT) - 4 SEC Filings 12/16/2020
Artivion, Inc. (AORT) - 4 SEC Filings 12/15/2020
Artivion, Inc. (AORT) - 4 SEC Filings 12/14/2020
Artivion, Inc. (AORT) - 4 SEC Filings 12/03/2020
Artivion, Inc. (AORT) - 4 SEC Filings 12/02/2020
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 11/05/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/04/2020
Artivion, Inc. (AORT) - 4 SEC Filings 11/04/2020
Artivion, Inc. (AORT) - 4/A SEC Filings 10/01/2020
Artivion, Inc. (AORT) - 4 SEC Filings 09/17/2020
Artivion, Inc. (AORT) - 4 SEC Filings 09/16/2020
Artivion, Inc. (AORT) - D SEC Filings 09/14/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/02/2020
Artivion, Inc. (AORT) - S-8 SEC Filings 08/11/2020
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/31/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/30/2020
Artivion, Inc. (AORT) - 3 SEC Filings 07/01/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/23/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/19/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/18/2020
Artivion, Inc. (AORT) - 4 SEC Filings 06/02/2020
Artivion, Inc. (AORT) - SD SEC Filings 06/01/2020
Artivion, Inc. (AORT) - 4 SEC Filings 05/29/2020
Artivion, Inc. (AORT) - 4 SEC Filings 05/27/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/22/2020
Artivion, Inc. (AORT) - DEFA14A SEC Filings 05/14/2020
Artivion, Inc. (AORT) - 4 SEC Filings 05/07/2020
Artivion, Inc. (AORT) - 4 SEC Filings 05/06/2020
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 05/01/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/30/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/01/2020
Artivion, Inc. (AORT) - DEF 14A SEC Filings 03/31/2020
Artivion, Inc. (AORT) - 4 SEC Filings 03/16/2020
Artivion, Inc. (AORT) - 4 SEC Filings 03/09/2020
Artivion, Inc. (AORT) - 4 SEC Filings 02/25/2020
Artivion, Inc. (AORT) - 4 SEC Filings 02/21/2020
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/19/2020
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2020
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/13/2020
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/12/2020
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/04/2020
Artivion, Inc. (AORT) - 5 SEC Filings 01/29/2020
Artivion, Inc. (AORT) - 4 SEC Filings 01/23/2020
Artivion, Inc. (AORT) - 4 SEC Filings 01/21/2020
Artivion, Inc. (AORT) - 4 SEC Filings 12/13/2019
Artivion, Inc. (AORT) - 4 SEC Filings 11/27/2019
Artivion, Inc. (AORT) - 4 SEC Filings 11/19/2019
Artivion, Inc. (AORT) - 4 SEC Filings 11/13/2019
Artivion, Inc. (AORT) - 4 SEC Filings 11/07/2019
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/31/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/30/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/11/2019
Artivion, Inc. (AORT) - 3 SEC Filings 08/08/2019
Artivion, Inc. (AORT) - 5 SEC Filings 08/05/2019
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/31/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/30/2019
Artivion, Inc. (AORT) - 4 SEC Filings 06/06/2019
Artivion, Inc. (AORT) - 4 SEC Filings 06/03/2019
Artivion, Inc. (AORT) - SD SEC Filings 05/31/2019
Artivion, Inc. (AORT) - 4 SEC Filings 05/29/2019
Artivion, Inc. (AORT) - 4 SEC Filings 05/24/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/17/2019
Artivion, Inc. (AORT) - 4 SEC Filings 05/17/2019
Artivion, Inc. (AORT) - 4 SEC Filings 05/14/2019
Artivion, Inc. (AORT) - 4 SEC Filings 05/07/2019
Artivion, Inc. (AORT) - 4 SEC Filings 05/03/2019
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 05/02/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/30/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/01/2019
Artivion, Inc. (AORT) - DEFA14A SEC Filings 03/26/2019
Artivion, Inc. (AORT) - DEF 14A SEC Filings 03/26/2019
Artivion, Inc. (AORT) - 4 SEC Filings 03/18/2019
Artivion, Inc. (AORT) - PRE 14A SEC Filings 03/15/2019
Artivion, Inc. (AORT) - 4 SEC Filings 03/08/2019
Artivion, Inc. (AORT) - 4 SEC Filings 03/07/2019
Artivion, Inc. (AORT) - 4 SEC Filings 03/04/2019
Artivion, Inc. (AORT) - S-8 SEC Filings 02/26/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/26/2019
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/26/2019
Artivion, Inc. (AORT) - 4 SEC Filings 02/25/2019
Artivion, Inc. (AORT) - 4 SEC Filings 02/21/2019
Artivion, Inc. (AORT) - 5 SEC Filings 02/19/2019
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/15/2019
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2019
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/14/2019
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/14/2019
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/12/2019
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/08/2019
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/24/2019
Artivion, Inc. (AORT) - 3 SEC Filings 12/11/2018
Artivion, Inc. (AORT) - 10-Q/A - Quarterly Report SEC Filings 11/19/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/01/2018
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 11/01/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/31/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/16/2018
Artivion, Inc. (AORT) - S-3ASR SEC Filings 09/21/2018
Artivion, Inc. (AORT) - CT ORDER SEC Filings 09/21/2018
Artivion, Inc. (AORT) - 4 SEC Filings 09/20/2018
Artivion, Inc. (AORT) - 4 SEC Filings 09/12/2018
Artivion, Inc. (AORT) - 4 SEC Filings 09/06/2018
Artivion, Inc. (AORT) - 4 SEC Filings 09/04/2018
Artivion, Inc. (AORT) - 4 SEC Filings 08/29/2018
Artivion, Inc. (AORT) - 4 SEC Filings 08/21/2018
Artivion, Inc. (AORT) - 4 SEC Filings 08/16/2018
Artivion, Inc. (AORT) - 4 SEC Filings 08/15/2018
Artivion, Inc. (AORT) - 4 SEC Filings 08/13/2018
Artivion, Inc. (AORT) - 4 SEC Filings 08/09/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/07/2018
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 08/07/2018
Artivion, Inc. (AORT) - 4 SEC Filings 07/30/2018
Artivion, Inc. (AORT) - 4 SEC Filings 07/25/2018
Artivion, Inc. (AORT) - CT ORDER SEC Filings 07/13/2018
Artivion, Inc. (AORT) - 4 SEC Filings 07/10/2018
Artivion, Inc. (AORT) - 3 SEC Filings 06/27/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/20/2018
Artivion, Inc. (AORT) - 4 SEC Filings 06/15/2018
Artivion, Inc. (AORT) - 4 SEC Filings 06/05/2018
Artivion, Inc. (AORT) - 3 SEC Filings 06/05/2018
Artivion, Inc. (AORT) - 4 SEC Filings 06/01/2018
Artivion, Inc. (AORT) - SD SEC Filings 05/31/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/25/2018
Artivion, Inc. (AORT) - 4 SEC Filings 05/25/2018
Artivion, Inc. (AORT) - 4 SEC Filings 05/18/2018
Artivion, Inc. (AORT) - 4 SEC Filings 05/15/2018
Artivion, Inc. (AORT) - 4 SEC Filings 05/11/2018
Artivion, Inc. (AORT) - 4 SEC Filings 05/10/2018
Artivion, Inc. (AORT) - 4 SEC Filings 05/08/2018
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 05/04/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/03/2018
Artivion, Inc. (AORT) - 4 SEC Filings 04/18/2018
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/03/2018
Artivion, Inc. (AORT) - 4 SEC Filings 04/03/2018
Artivion, Inc. (AORT) - 4 SEC Filings 03/26/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/14/2018
Artivion, Inc. (AORT) - 4 SEC Filings 03/14/2018
Artivion, Inc. (AORT) - 4 SEC Filings 03/09/2018
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 03/09/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/08/2018
Artivion, Inc. (AORT) - 4 SEC Filings 03/07/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/22/2018
Artivion, Inc. (AORT) - 4 SEC Filings 02/21/2018
Artivion, Inc. (AORT) - 8-K/A - Current report SEC Filings 02/16/2018
Artivion, Inc. (AORT) - 4 SEC Filings 02/15/2018
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2018
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/14/2018
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/12/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/12/2018
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/09/2018
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/31/2018
Artivion, Inc. (AORT) - 5 SEC Filings 01/25/2018
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/23/2018
Artivion, Inc. (AORT) - 3 SEC Filings 01/05/2018
Artivion, Inc. (AORT) - 4 SEC Filings 12/19/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/01/2017
Artivion, Inc. (AORT) - 4 SEC Filings 11/17/2017
Artivion, Inc. (AORT) - 4 SEC Filings 11/13/2017
Artivion, Inc. (AORT) - 4 SEC Filings 11/08/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/31/2017
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/31/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/11/2017
Artivion, Inc. (AORT) - 4 SEC Filings 10/04/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/02/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/07/2017
Artivion, Inc. (AORT) - 4/A SEC Filings 09/06/2017
Artivion, Inc. (AORT) - 4 SEC Filings 09/06/2017
Artivion, Inc. (AORT) - 8-K/A - Current report SEC Filings 08/10/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/25/2017
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/25/2017
Artivion, Inc. (AORT) - 5 SEC Filings 07/11/2017
Artivion, Inc. (AORT) - 4 SEC Filings 07/06/2017
Artivion, Inc. (AORT) - 4 SEC Filings 06/29/2017
Artivion, Inc. (AORT) - SD SEC Filings 05/26/2017
Artivion, Inc. (AORT) - 4 SEC Filings 05/24/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/23/2017
Artivion, Inc. (AORT) - 4 SEC Filings 05/18/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/27/2017
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/27/2017
Artivion, Inc. (AORT) - 4 SEC Filings 04/10/2017
Artivion, Inc. (AORT) - DEF 14A SEC Filings 03/29/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/23/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/16/2017
Artivion, Inc. (AORT) - 4 SEC Filings 02/28/2017
Artivion, Inc. (AORT) - 4 SEC Filings 02/24/2017
Artivion, Inc. (AORT) - 4 SEC Filings 02/22/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/21/2017
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/16/2017
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/16/2017
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/13/2017
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/13/2017
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/09/2017
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/30/2017
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/09/2017
Artivion, Inc. (AORT) - 4 SEC Filings 01/05/2017
Artivion, Inc. (AORT) - 4 SEC Filings 11/28/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/22/2016
Artivion, Inc. (AORT) - 4 SEC Filings 11/16/2016
Artivion, Inc. (AORT) - S-3 SEC Filings 11/14/2016
Artivion, Inc. (AORT) - 3 SEC Filings 11/08/2016
Artivion, Inc. (AORT) - 4 SEC Filings 11/01/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/27/2016
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/27/2016
Artivion, Inc. (AORT) - 4 SEC Filings 09/22/2016
Artivion, Inc. (AORT) - 4 SEC Filings 09/16/2016
Artivion, Inc. (AORT) - 4 SEC Filings 09/15/2016
Artivion, Inc. (AORT) - 4 SEC Filings 09/14/2016
Artivion, Inc. (AORT) - 3 SEC Filings 09/14/2016
Artivion, Inc. (AORT) - 4 SEC Filings 09/13/2016
Artivion, Inc. (AORT) - 4 SEC Filings 07/28/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/26/2016
Artivion, Inc. (AORT) - 4 SEC Filings 07/26/2016
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/26/2016
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 06/21/2016
Artivion, Inc. (AORT) - 4 SEC Filings 06/03/2016
Artivion, Inc. (AORT) - SD SEC Filings 05/31/2016
Artivion, Inc. (AORT) - 4 SEC Filings 05/25/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/23/2016
Artivion, Inc. (AORT) - 4 SEC Filings 05/12/2016
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/29/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/28/2016
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/21/2016
Artivion, Inc. (AORT) - 4 SEC Filings 04/19/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/14/2016
Artivion, Inc. (AORT) - 424B3 SEC Filings 03/29/2016
Artivion, Inc. (AORT) - CORRESP SEC Filings 03/25/2016
Artivion, Inc. (AORT) - 10-K/A - Current report SEC Filings 03/25/2016
Artivion, Inc. (AORT) - S-3/A SEC Filings 03/23/2016
Artivion, Inc. (AORT) - UPLOAD SEC Filings 03/21/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/18/2016
Artivion, Inc. (AORT) - DEL AM SEC Filings 03/16/2016
Artivion, Inc. (AORT) - CORRESP SEC Filings 03/15/2016
Artivion, Inc. (AORT) - S-3 SEC Filings 03/09/2016
Artivion, Inc. (AORT) - 8-K/A - Current report SEC Filings 03/09/2016
Artivion, Inc. (AORT) - 4 SEC Filings 03/09/2016
Artivion, Inc. (AORT) - 4 SEC Filings 03/04/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/01/2016
Artivion, Inc. (AORT) - 4/A SEC Filings 03/01/2016
Artivion, Inc. (AORT) - 4 SEC Filings 03/01/2016
Artivion, Inc. (AORT) - 4 SEC Filings 02/23/2016
Artivion, Inc. (AORT) - 3 SEC Filings 02/23/2016
Artivion, Inc. (AORT) - 4 SEC Filings 02/19/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/16/2016
Artivion, Inc. (AORT) - 4 SEC Filings 02/16/2016
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/16/2016
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/11/2016
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/09/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/08/2016
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/03/2016
Artivion, Inc. (AORT) - SC 13G SEC Filings 01/28/2016
Artivion, Inc. (AORT) - D SEC Filings 01/28/2016
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/26/2016
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/25/2016
Artivion, Inc. (AORT) - 4 SEC Filings 12/30/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/23/2015
Artivion, Inc. (AORT) - 4 SEC Filings 12/01/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/23/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/17/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/27/2015
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/27/2015
Artivion, Inc. (AORT) - 4 SEC Filings 10/23/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/13/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/09/2015
Artivion, Inc. (AORT) - 4/A SEC Filings 09/17/2015
Artivion, Inc. (AORT) - 4 SEC Filings 09/17/2015
Artivion, Inc. (AORT) - 3 SEC Filings 09/17/2015
Artivion, Inc. (AORT) - 4/A SEC Filings 09/15/2015
Artivion, Inc. (AORT) - 4 SEC Filings 09/15/2015
Artivion, Inc. (AORT) - 3 SEC Filings 09/15/2015
Artivion, Inc. (AORT) - 4 SEC Filings 09/14/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/09/2015
Artivion, Inc. (AORT) - CORRESP SEC Filings 09/02/2015
Artivion, Inc. (AORT) - S-3/A SEC Filings 08/21/2015
Artivion, Inc. (AORT) - S-3 SEC Filings 08/05/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/28/2015
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/28/2015
Artivion, Inc. (AORT) - 4 SEC Filings 06/04/2015
Artivion, Inc. (AORT) - SD SEC Filings 05/29/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/26/2015
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/29/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/28/2015
Artivion, Inc. (AORT) - DEFA14A SEC Filings 04/27/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/27/2015
Artivion, Inc. (AORT) - ARS SEC Filings 04/24/2015
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/20/2015
Artivion, Inc. (AORT) - 4/A SEC Filings 04/15/2015
Artivion, Inc. (AORT) - 4 SEC Filings 04/13/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/10/2015
Artivion, Inc. (AORT) - 4 SEC Filings 04/02/2015
Artivion, Inc. (AORT) - 3 SEC Filings 04/02/2015
Artivion, Inc. (AORT) - 4 SEC Filings 03/10/2015
Artivion, Inc. (AORT) - CT ORDER SEC Filings 02/27/2015
Artivion, Inc. (AORT) - 4 SEC Filings 02/27/2015
Artivion, Inc. (AORT) - 4 SEC Filings 02/25/2015
Artivion, Inc. (AORT) - 8-K/A - Current report SEC Filings 02/23/2015
Artivion, Inc. (AORT) - 4/A SEC Filings 02/20/2015
Artivion, Inc. (AORT) - 4 SEC Filings 02/20/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/18/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/17/2015
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/17/2015
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/13/2015
Artivion, Inc. (AORT) - 4 SEC Filings 02/13/2015
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/05/2015
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/15/2015
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/30/2014
Artivion, Inc. (AORT) - 4 SEC Filings 12/10/2014
Artivion, Inc. (AORT) - 4 SEC Filings 12/05/2014
Artivion, Inc. (AORT) - 4 SEC Filings 12/04/2014
Artivion, Inc. (AORT) - 4 SEC Filings 11/26/2014
Artivion, Inc. (AORT) - 4 SEC Filings 11/12/2014
Artivion, Inc. (AORT) - 4 SEC Filings 11/06/2014
Artivion, Inc. (AORT) - 4 SEC Filings 11/04/2014
Artivion, Inc. (AORT) - 4 SEC Filings 11/03/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/28/2014
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/28/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/27/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/24/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/01/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/09/2014
Artivion, Inc. (AORT) - 4 SEC Filings 09/09/2014
Artivion, Inc. (AORT) - 4 SEC Filings 09/04/2014
Artivion, Inc. (AORT) - 3 SEC Filings 09/04/2014
Artivion, Inc. (AORT) - 4 SEC Filings 09/03/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/02/2014
Artivion, Inc. (AORT) - 4 SEC Filings 08/26/2014
Artivion, Inc. (AORT) - CT ORDER SEC Filings 08/25/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/22/2014
Artivion, Inc. (AORT) - 4 SEC Filings 08/19/2014
Artivion, Inc. (AORT) - 4 SEC Filings 08/15/2014
Artivion, Inc. (AORT) - 4 SEC Filings 08/14/2014
Artivion, Inc. (AORT) - 4 SEC Filings 07/31/2014
Artivion, Inc. (AORT) - 4 SEC Filings 07/29/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/24/2014
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/24/2014
Artivion, Inc. (AORT) - S-8 SEC Filings 07/21/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/11/2014
Artivion, Inc. (AORT) - 4 SEC Filings 06/12/2014
Artivion, Inc. (AORT) - 4 SEC Filings 06/11/2014
Artivion, Inc. (AORT) - SD SEC Filings 05/29/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/27/2014
Artivion, Inc. (AORT) - 4 SEC Filings 05/19/2014
Artivion, Inc. (AORT) - 4 SEC Filings 05/14/2014
Artivion, Inc. (AORT) - 4 SEC Filings 05/06/2014
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/30/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/29/2014
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/08/2014
Artivion, Inc. (AORT) - ARS SEC Filings 04/08/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/08/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/31/2014
Artivion, Inc. (AORT) - 4 SEC Filings 03/10/2014
Artivion, Inc. (AORT) - 4 SEC Filings 02/26/2014
Artivion, Inc. (AORT) - 4 SEC Filings 02/25/2014
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/21/2014
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/20/2014
Artivion, Inc. (AORT) - 4 SEC Filings 02/20/2014
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2014
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/10/2014
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 01/31/2014
Artivion, Inc. (AORT) - 4 SEC Filings 12/31/2013
Artivion, Inc. (AORT) - 4 SEC Filings 12/20/2013
Artivion, Inc. (AORT) - 4 SEC Filings 12/02/2013
Artivion, Inc. (AORT) - 4 SEC Filings 11/26/2013
Artivion, Inc. (AORT) - 4 SEC Filings 11/13/2013
Artivion, Inc. (AORT) - 4 SEC Filings 11/12/2013
Artivion, Inc. (AORT) - 4 SEC Filings 11/07/2013
Artivion, Inc. (AORT) - 4 SEC Filings 11/06/2013
Artivion, Inc. (AORT) - 4 SEC Filings 11/05/2013
Artivion, Inc. (AORT) - 4 SEC Filings 10/31/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/29/2013
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/29/2013
Artivion, Inc. (AORT) - 4 SEC Filings 08/28/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/20/2013
Artivion, Inc. (AORT) - 4 SEC Filings 08/14/2013
Artivion, Inc. (AORT) - 4 SEC Filings 08/09/2013
Artivion, Inc. (AORT) - 4 SEC Filings 08/02/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/25/2013
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/25/2013
Artivion, Inc. (AORT) - 4 SEC Filings 07/16/2013
Artivion, Inc. (AORT) - 4 SEC Filings 06/27/2013
Artivion, Inc. (AORT) - 4 SEC Filings 06/07/2013
Artivion, Inc. (AORT) - 4 SEC Filings 06/03/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/28/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/21/2013
Artivion, Inc. (AORT) - 4 SEC Filings 05/20/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/30/2013
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/30/2013
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/03/2013
Artivion, Inc. (AORT) - ARS SEC Filings 04/03/2013
Artivion, Inc. (AORT) - 4 SEC Filings 03/11/2013
Artivion, Inc. (AORT) - 4 SEC Filings 02/26/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/22/2013
Artivion, Inc. (AORT) - 4 SEC Filings 02/19/2013
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/15/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/14/2013
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/13/2013
Artivion, Inc. (AORT) - SC 13G SEC Filings 02/11/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/05/2013
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/01/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/01/2013
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/14/2013
Artivion, Inc. (AORT) - 4 SEC Filings 12/26/2012
Artivion, Inc. (AORT) - 3 SEC Filings 12/14/2012
Artivion, Inc. (AORT) - CT ORDER SEC Filings 12/13/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/13/2012
Artivion, Inc. (AORT) - 4 SEC Filings 12/03/2012
Artivion, Inc. (AORT) - 4 SEC Filings 11/15/2012
Artivion, Inc. (AORT) - 4 SEC Filings 11/13/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/30/2012
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/30/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/29/2012
Artivion, Inc. (AORT) - 4 SEC Filings 08/28/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 08/23/2012
Artivion, Inc. (AORT) - 8-K/A - Current report SEC Filings 08/01/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/31/2012
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/31/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/26/2012
Artivion, Inc. (AORT) - S-8 SEC Filings 06/22/2012
Artivion, Inc. (AORT) - S-4 SEC Filings 06/22/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/22/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 06/14/2012
Artivion, Inc. (AORT) - 4 SEC Filings 06/11/2012
Artivion, Inc. (AORT) - 4 SEC Filings 06/05/2012
Artivion, Inc. (AORT) - 4 SEC Filings 05/31/2012
Artivion, Inc. (AORT) - 4 SEC Filings 05/23/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/21/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/18/2012
Artivion, Inc. (AORT) - 4 SEC Filings 05/18/2012
Artivion, Inc. (AORT) - 3 SEC Filings 05/18/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 05/16/2012
Artivion, Inc. (AORT) - DEFA14A SEC Filings 05/09/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 04/26/2012
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 04/26/2012
Artivion, Inc. (AORT) - CORRESP SEC Filings 04/25/2012
Artivion, Inc. (AORT) - CT ORDER SEC Filings 04/23/2012
Artivion, Inc. (AORT) - DEF 14A SEC Filings 04/06/2012
Artivion, Inc. (AORT) - ARS SEC Filings 04/06/2012
Artivion, Inc. (AORT) - CT ORDER SEC Filings 04/02/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/22/2012
Artivion, Inc. (AORT) - UPLOAD SEC Filings 03/21/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 03/13/2012
Artivion, Inc. (AORT) - S-3 SEC Filings 02/22/2012
Artivion, Inc. (AORT) - 4 SEC Filings 02/22/2012
Artivion, Inc. (AORT) - 4 SEC Filings 02/21/2012
Artivion, Inc. (AORT) - 10-K - Current report SEC Filings 02/17/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 02/16/2012
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/14/2012
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/09/2012
Artivion, Inc. (AORT) - SC 13G/A SEC Filings 02/08/2012
Artivion, Inc. (AORT) - 4 SEC Filings 02/08/2012
Artivion, Inc. (AORT) - 4 SEC Filings 02/07/2012
Artivion, Inc. (AORT) - CT ORDER SEC Filings 02/06/2012
Artivion, Inc. (AORT) - CT ORDER SEC Filings 02/02/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/30/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 01/18/2012
Artivion, Inc. (AORT) - 3 SEC Filings 01/09/2012
Artivion, Inc. (AORT) - 4 SEC Filings 01/04/2012
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 12/21/2011
Artivion, Inc. (AORT) - 4 SEC Filings 12/16/2011
Artivion, Inc. (AORT) - 4 SEC Filings 12/07/2011
Artivion, Inc. (AORT) - 4 SEC Filings 11/23/2011
Artivion, Inc. (AORT) - CT ORDER SEC Filings 11/21/2011
Artivion, Inc. (AORT) - 4 SEC Filings 11/21/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/15/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/09/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 11/03/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 10/27/2011
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 10/27/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 09/06/2011
Artivion, Inc. (AORT) - 4 SEC Filings 08/23/2011
Artivion, Inc. (AORT) - 4 SEC Filings 08/17/2011
Artivion, Inc. (AORT) - 4 SEC Filings 08/11/2011
Artivion, Inc. (AORT) - 10-Q - Quarterly Report SEC Filings 07/29/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/28/2011
Artivion, Inc. (AORT) - 4 SEC Filings 07/28/2011
Artivion, Inc. (AORT) - 8-K - Current report SEC Filings 07/27/2011
Artivion, Inc. (AORT) - CT ORDER SEC Filings 07/22/2011

Press Releases

StockPrice Release
Artivion granted fda humanitarian device exemption for the amds hybrid prosthesis 12/09/2024
Artivion reports third quarter 2024 financial results 11/07/2024
Artivion to participate in upcoming investor conferences 11/05/2024
Artivion announces release date and teleconference call details for third quarter 2024 financial results 10/24/2024
Artivion announces presentation of late-breaking clinical data at the 38th european association for cardio-thoracic surgery (eacts) annual meeting 10/10/2024
Artivion reports second quarter 2024 financial results 08/08/2024
Artivion to participate in upcoming investor conferences 08/05/2024
Artivion announces release date and teleconference call details for second quarter 2024 financial results 07/25/2024
Artivion amends agreements with endospan 07/01/2024
Artivion reports first quarter 2024 financial results 05/06/2024
Artivion announces presentation of new clinical data for on-x aortic heart valve and amds at the 104th american association for thoracic surgery (aats) annual meeting 04/29/2024
Artivion announces release date and teleconference call details for first quarter 2024 financial results 04/22/2024
Artivion to participate in the 23rd annual needham virtual healthcare conference 04/01/2024
Artivion to participate in the oppenheimer 34th annual healthcare medtech & services conference 03/06/2024
Artivion reports fourth quarter and full year 2023 financial results 02/15/2024
Artivion announces release date and teleconference call details for fourth quarter and full year 2023 financial results 02/01/2024
Artivion announces presentation of late-breaking data from amds persevere trial at the 60th society of thoracic surgery annual meeting 01/29/2024
Artivion obtains $350 million in senior secured credit facilities 01/18/2024
Artivion appoints lance a. berry as executive vice president, chief financial officer; announces retirement of d. 12/06/2023
Artivion announces completion of enrollment in persevere trial 11/09/2023
Artivion to participate in upcoming investor conferences 11/08/2023
Artivion announces release date and teleconference call details for third quarter 2023 financial results 10/19/2023
Artivion announces presentation of real world data from post market study of on-x® aortic heart valve replacement patients treated with low dose warfarin 10/05/2023
Artivion announces presentation of late-breaking interim data from amds persevere trial at the 37th european association for cardio-thoracic surgery annual meeting 10/05/2023
Artivion to present at the deutsche bank 31st annual leveraged finance conference 09/26/2023
Artivion to present at the gilmartin group emerging growth company showcase 09/14/2023
Artivion reports second quarter 2023 financial results 08/03/2023
Artivion to participate in upcoming investor conferences 08/01/2023
Artivion announces release date and teleconference call details for second quarter 2023 financial results 07/20/2023
Artivion announces fda pma approval of perclot and transfer of pma to baxter 05/23/2023
Artivion announces release date and teleconference call details for first quarter 2023 financial results 04/20/2023
Artivion to participate in the 22nd annual needham virtual healthcare conference 04/10/2023
Artivion to participate in the oppenheimer 33rd annual healthcare conference 03/06/2023
Artivion announces release date and teleconference call details for fourth quarter and full year 2022 financial results 02/02/2023
Elizabeth hoff joins artivion board of directors 09/29/2022
Artivion follows recommendation to stop proact xa clinical trial 09/23/2022
Artivion to present at the deutsche bank 30th annual leveraged finance conference 09/14/2022
Artivion to participate in upcoming investor conferences 09/06/2022
Artivion to present at the gilmartin group emerging growth company showcase 08/24/2022
Artivion initiates enrollment in persevere clinical trial 07/27/2022
Artivionannounces release date and teleconference call details for first quarter 2022 financial results 04/21/2022
Artivion publishes inaugural corporate responsibility report 03/14/2022
Artivion to host investor & analyst day on march 23, 2022 03/09/2022

More Headlines

News
Artivion to Participate in Upcoming Investor Conferences ATLANTA , Nov. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion's management team will present at the upcoming Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at the Lotte New York Palace. 11/05/2024
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results ATLANTA , Oct. 24, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2024 financial results will be released on Thursday, November 7, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. 10/24/2024
Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting 5-Year Data from the AMDS DARTS Trial Demonstrates Positive Aortic Remodeling with 94% of Patients Free from Unanticipated Reoperation 30-Day Data from the AMDS PERSEVERE Trial Shows Cerebral Malperfusion Resolution in 90% of Affected Subjects Post-AMDS Implantation 1-Year Data from the NEOS Study Indicate E-vita Open Neo is Safe and Effective in the Treatment of Aortic Arch Pathologies with Low Combined Major Adverse Events Rate ATLANTA , Oct. 10, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its AMDS DARTS and PERSEVERE trials and E-vita Open Neo study presented in Late-Breaking Science presentations at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Lisbon, Portugal. The presentation regarding the AMDS DARTS trial highlighted 5-year aortic remodeling data that demonstrate positive, durable patient outcomes following AMDS implantation. 10/10/2024
Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Eileen Martin - Investor Relations Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Suraj Kalia - Oppenheimer John McAulay - Stifel Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. And welcome to Artivion's Second Quarter 2024 Financial Conference Call. 08/10/2024
Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates Artivion (AORT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.06 per share a year ago. 08/08/2024
Artivion Reports Second Quarter 2024 Financial Results Second Quarter Highlights: Achieved revenue of $98.0 million in the second quarter of 2024 versus $89.3 million in the second quarter of 2023, an increase of 10% on both a GAAP and constant currency basis Net loss was ($2.1) million or ($0.05) per fully diluted share and non-GAAP net income was $2.9 million or $0.07 per fully diluted share in the second quarter of 2024 Adjusted EBITDA increased 35% to $18.6 million in the second quarter of 2024 compared to $13.8 million in the second quarter of 2023 Raised FY24 revenue guidance to 10% to 12% year-over-year growth on a constant currency basis, an increase of 0.5% at the midpoint Raised FY24 adjusted EBITDA guidance to 28% to 34% year-over-year growth, an increase of 1% at the midpoint ATLANTA , Aug. 8, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the second quarter ended June 30, 2024. "In the second quarter, we continued to make substantial progress on our strategic growth initiatives to drive sustained and profitable growth, and we further solidified our position as the leader in the aortic disease space. 08/08/2024
Artivion to Participate in Upcoming Investor Conferences ATLANTA , Aug. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion's management team will present at the upcoming Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024 at the InterContinental Boston Hotel. 08/05/2024
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results ATLANTA , July 25, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2024 financial results will be released on Thursday, August 8, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. 07/25/2024
3 Earnings All-Stars With More Room to Run Earnings are essential to determining which stocks will outperform. Unsurprisingly, earnings outperformers also see strong price appreciation. 07/03/2024
Artivion Amends Agreements with Endospan Provides Endospan with $25 million of Additional Debt Funding to Obtain FDA Approval for NEXUS Upfront Payment Associated with Purchase Option Reduced to $135 million, inclusive of loan off-set, and $100 million earnout minimum eliminated ATLANTA , July 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced it has amended its credit facility and option purchase agreements with Endospan Ltd. ("Endospan"), an Israeli-based, privately-held developer of the NEXUS® Stent Graft System ("NEXUS"). 07/01/2024
Data-Driven Growth Fuels More Upside For Overlooked Artivion Artivion, Inc. has continued to log double-digit revenue growth with contributions from diverse assets including its stent grafts, heart valves, and cryopreserved tissue grafts. Positive post-approval trial data for the On-X aortic valve and a successful PERSEVERE IDE study for AMDS hybrid prosthesis can drive additional revenue growth. A strong pipeline, including NEXUS and ARCEVO stent graft systems, can support a longer runway of continued revenue growth. 06/21/2024
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. 05/08/2024
Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Eileen Martin - Investor Relations Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants Mike Matson - Needham & Company Suraj Kalia - Oppenheimer & Company Frank Takkinen - Lake Street Capital Markets Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. Welcome to Artivion First Quarter 2024 Financial Conference Call. 05/06/2024
Artivion (AORT) Tops Q1 Earnings and Revenue Estimates Artivion (AORT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago. 05/06/2024
Artivion Reports First Quarter 2024 Financial Results First Quarter Highlights: Achieved revenue of $97.4 million in the first quarter of 2024 versus $83.2 million in the first quarter of 2023, an increase of 17% on a GAAP basis and 16% on a non-GAAP constant currency basis Net income was $7.5 million or $0.18 per fully diluted share and non-GAAP net income was $2.6 million or $0.06 per fully diluted share in the first quarter of 2024 Non-GAAP adjusted EBITDA increased 60% to $17.3 million in the first quarter of 2024 compared to $10.8 million in the first quarter of 2023 Revised FY24 revenue guidance to 9% to 12% year-over-year growth on a constant currency basis, an increase of 0.5% at the midpoint ATLANTA , May 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the first quarter ended March 31, 2024. "We are very pleased with our first quarter results as we maintained growth momentum and executed on key operational priorities. 05/06/2024
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting 5-Year Real-World Safety and Efficacy Data from On-X Aortic Heart Valve Low INR Post-Market Study Demonstrate Even Better Patient Outcomes Than Predicted by the PROACT IDE Study Late-Breaking 30-Day Data from AMDS PERSEVERE Trial Demonstrate Positive Aortic Remodeling Outcomes and Zero DANE Tears ATLANTA , April 29, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of new clinical data from the On-X Low INR post-market study and AMDS PERSEVERE Trial at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting in Toronto, Canada. Presentations highlighted 5-year real-world safety and efficacy data from the On-X Aortic Heart Valve Low INR post-market study that demonstrate even better patient outcomes than predicted by the On-X Aortic Heart Valve PROACT IDE Study, as well as Late-Breaking data from the AMDS PERSEVERE Trial demonstrating, at 30-days post-AMDS implantation, positive aortic remodeling outcomes and zero distal anastomotic new entry (DANE) tears. 04/29/2024
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results ATLANTA , April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial results will be released on Monday, May 6, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. 04/22/2024
Is Artivion (AORT) Outperforming Other Medical Stocks This Year? Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year. 04/15/2024
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference ATLANTA, April 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming 23rd Annual Needham Virtual Healthcare Conference. The Company's virtual fireside chat is scheduled to begin at 10:15 a.m. 04/01/2024
Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run? Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. 03/29/2024
Are Medical Stocks Lagging Artivion (AORT) This Year? Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year. 03/28/2024
3 Buy-Rated Small Caps Flexing Big Growth Small-cap stocks can be solid considerations for those who can handle a higher level of volatility. Analysts have recently become bullish on these three. 03/19/2024
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024 We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW. 03/14/2024
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year. 03/12/2024
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference ATLANTA , March 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m. 03/06/2024
Is Artivion (AORT) Outperforming Other Medical Stocks This Year? Here is how Artivion (AORT) and Boston Scientific (BSX) have performed compared to their sector so far this year. 02/22/2024
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. 02/22/2024
Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 02/21/2024
Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript 02/15/2024
Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates Artivion (AORT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to earnings of $0.10 per share a year ago. 02/15/2024
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results Fourth Quarter and Recent Business Highlights: Achieved revenue of $93.7 million in the fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis Achieved revenue of $354.0 million for the full year of 2023 versus $313.8 million for the full year of 2022, an increase of 13% on a GAAP basis and 12% on a non-GAAP constant currency basis Net loss was ($4.0) million or ($0.10) per fully diluted share and non-GAAP net income was $4.6 million or $0.11 per fully diluted share in the fourth quarter of 2023 Non-GAAP adjusted EBITDA increased 40% to $15.3 million in the fourth quarter of 2023 compared to $11.0 million in the fourth quarter of 2022. For the full year adjusted EBITDA increased 29.5% to $53.8 million Generated $11.4 million of free cash flow for the full year of 2023 Closed non-dilutive credit agreement for $350.0 million of senior secured, interest-only, credit facilities with 6-year maturities Completed enrollment of the AMDS PERSEVERE clinical trial and presented positive results of the full IDE cohort at the STS Annual Meeting demonstrating a significant reduction of all-cause mortality and primary major adverse events (MAEs) at 30-days following AMDS implantation Appointed Lance A. 02/15/2024
This suspicious congressional trade returned 48% in two months Reports of various elected U.S. officials making significant, conveniently timed trades are not, unfortunately, rare. While much focus has been given to Nancy Pelosi and her husband – and indeed, their trading strategy has so far proven successful, as made evident by the returns of a trading bot that copies their investments – Senator Tina Smith has been increasingly in the news in the final months of 2023. 12/27/2023
This trading bot buys stocks bought by US politicians; Here are its biggest holdings In May 2022, Quiver Quantitative, an alternative data platform catering to retail investors, introduced a trading bot that mimics the stock purchases made by influential US politicians. 12/22/2023
Senator up 30% on this year's two most suspicious trades Largely thanks to the efforts of the online investor community, interesting, suspicious, and conveniently timed trades made by elected officials in the U.S. have come under increased scrutiny in recent years. 12/13/2023
Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group Pat Mackin - Chairman, President, and Chief Executive Officer Ashley Lee - Executive Vice President and Chief Financial Officer Conference Call Participants John McAulay - Stifel Shaymus Contorno - Oppenheimer Joseph Stringer - Needham Frank Takkinen - Lake Street Capital Jeffrey Cohen - Ladenburg Thalmann Operator Welcome to the Artivion Third Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode. 11/05/2023
Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025 Artivion has used M&A to reposition itself towards growth opportunities in aortic disease care and heart valves. The company's legacy operations contribute positively to revenue and margins but have limited growth prospects. The success of Artivion's stent-graft business and ongoing clinical trials will determine its future growth potential, as those trials are the gating factor to over $1.2B in potential revenue. 10/13/2023
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase ATLANTA , Sept. 14, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21, 2023. 09/14/2023
Is Artivion (AORT) Outperforming Other Medical Stocks This Year? Here is how Artivion (AORT) and Augmedix, Inc. (AUGX) have performed compared to their sector so far this year. 08/24/2023
Time to Buy These Medical Stocks as Earnings Approach Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well. 08/14/2023
Does Artivion (AORT) Have the Potential to Rally 52.78% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 52.8% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 08/10/2023
Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 AM ET Company Participants Laine Morgan – Gilmartin Group Pat Mackin – Chief Executive Officer Ashley Lee – Chief Financial Officer Conference Call Participants John McAulay – Stifel Shaymus Contorno – Oppenheimer Frank Takkinen – Lake Street Capital Markets Operator Greetings, and welcome to the Artivion Second Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode. 08/05/2023
Artivion (AORT) Q2 Earnings and Revenues Top Estimates Artivion (AORT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.03 per share a year ago. 08/03/2023
Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade) Artivion, Inc. has begun to recover from the fallout after its PROACT trial failure. On-X sales almost doubled the 5-year average range in Q1, and management look to 15% CAGR in sales moving forward. Net-net, revise to buy, eyeing $24 initial objective. 07/19/2023
Artivion, Inc. (AORT) Q1 2023 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Brian Johnston - Vice President, Gilmartin Group Pat Mackin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Jeffrey Cohen - Ladenburg Thalmann Frank Takkinen - Lake Street Capital Operator Good day, ladies and gentlemen. And welcome to the Artivion First Quarter 2023 Financial Conference Call. 05/07/2023
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results ATLANTA , April 20, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2023 financial results will be released on Thursday, May 4, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. 04/20/2023
Artivion: Reaffirm Hold As Pressures To Growth Remain Artivion: Reaffirm Hold As Pressures To Growth Remain. 04/20/2023
Why Artivion Stock Popped on Friday There's nothing like an upside earnings surprise to juice the price of a company's shares. 02/17/2023
Artivion, Inc. (AORT) Q4 2022 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q4 2022 Earnings Conference Call February 16, 2023 4:30 PM ET Company Participants Brian Johnston - Vice President at Gilmartin Group Pat Mackin - Chairman, President & CEO Ashley Lee - EVP & CFO Conference Call Participants Charlie Montang - Lake Street Jeffrey Cowen - Latin Bert, Dolman Rick Wise - Stifel Michael Matson - Needham and Company Suraj Kalia - Oppenheimer Operator Greetings and welcome to Artivion's Fourth Quarter and Full Year End 2022 Financial Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Brian Johnston, Vice President at Gilmartin Group. 02/16/2023
Artivion (AORT) Q4 Earnings Surpass Estimates Artivion (AORT) delivered earnings and revenue surprises of 158.82% and 1.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? 02/16/2023
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results ATLANTA , Feb. 2, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2022 financial results will be released on Thursday, February 16, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. 02/02/2023
Artivion (AORT) Upgraded to Buy: What Does It Mean for the Stock? Artivion (AORT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 11/25/2022
Artivion, Inc. (AORT) Q3 2022 Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Sam Bentzinger - Gilmartin Group Pat Mackin - Chairman, President & CEO Ashley Lee - EVP & CFO Conference Call Participants John McAulay - Stifel Frank Takkinen - Lake Street Capital Suraj Kalia - Oppenheimer & Co. Operator Good day, ladies and gentlemen, and welcome to the Artivion 3Q 2022 Financial Conference Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host, Sam Bentzinger from the Gilmartin Group. 11/05/2022
Artivion (AORT) Reports Q3 Loss, Tops Revenue Estimates Artivion (AORT) delivered earnings and revenue surprises of 54.55% and 0.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? 11/03/2022
Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver Artivion, Inc.'s decision to pull the PROACT Xa trial resulted in heavy downside for the share price. Investors have sold positions rapidly such that the stock trades at multi-year lows. 09/27/2022
Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference ATLANTA , Sept. 14, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at the upcoming Deutsche Bank 30th Annual Leveraged Finance Conference on Wednesday, September 21, 2022. 09/14/2022
Artivion to Participate in Upcoming Investor Conferences ATLANTA , Sept. 6, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. 09/06/2022
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase ATLANTA , Aug. 24, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase on Wednesday, August 31, 2022. The Company's presentation is scheduled to begin at 1:30 p.m. 08/24/2022
Artivion, Inc. (AORT) CEO James Mackin on Q2 2022 Results - Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Brian Johnston - Gilmartin Group James Mackin - Chairman, President & CEO David Lee - EVP, COO & CFO Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company Suraj Kalia - Oppenheimer Operator Greetings, and welcome to the Artivion Second Quarter 2022 Financial Results Conference Call. [Operator Instructions]. 08/07/2022
Artivion (AORT) Soars 10.2%: Is Further Upside Left in the Stock? Artivion (AORT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. 06/23/2022
Artivion, Inc. (AORT) CEO Pat Mackin on Q1 2022 Results - Earnings Call Transcript Artivion, Inc. (NYSE:AORT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Brian Johnston - Investor Relations Pat Mackin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Suraj Kalia - Oppenheimer Operator Greetings and welcome to the Artivion First Quarter 2022 Financial Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. 05/08/2022
Artivion, Inc. (AORT) CEO J. Patrick Mackin on Q4 2021 Results - Earnings Call Transcript Artivion, Inc. (AORT) CEO J. Patrick Mackin on Q4 2021 Results - Earnings Call Transcript 02/17/2022
Artivion (AORT) Reports Break-Even Earnings for Q4 Artivion (AORT) delivered earnings and revenue surprises of 100% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? 02/17/2022

Unlock

AORT Ratings Summary

AORT Quant Ranking